1. Home
  2. PII vs TMDX Comparison

PII vs TMDX Comparison

Compare PII & TMDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Polaris Inc.

PII

Polaris Inc.

HOLD

Current Price

$66.27

Market Cap

3.4B

ML Signal

HOLD

Logo TransMedics Group Inc.

TMDX

TransMedics Group Inc.

HOLD

Current Price

$98.10

Market Cap

3.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PII
TMDX
Founded
1954
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Recreational Games/Products/Toys
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.4B
3.8B
IPO Year
1994
2019

Fundamental Metrics

Financial Performance
Metric
PII
TMDX
Price
$66.27
$98.10
Analyst Decision
Hold
Buy
Analyst Count
11
9
Target Price
$60.64
$148.22
AVG Volume (30 Days)
1.9M
786.5K
Earning Date
04-27-2026
05-05-2026
Dividend Yield
4.09%
N/A
EPS Growth
N/A
382.18
EPS
N/A
4.87
Revenue
$7,152,000,000.00
$605,494,000.00
Revenue This Year
$1.20
$24.25
Revenue Next Year
$4.51
$18.75
P/E Ratio
N/A
$20.73
Revenue Growth
N/A
37.13
52 Week Low
$33.00
$89.10
52 Week High
$75.25
$156.00

Technical Indicators

Market Signals
Indicator
PII
TMDX
Relative Strength Index (RSI) 65.12 35.21
Support Level $62.12 $97.66
Resistance Level $69.04 $131.86
Average True Range (ATR) 4.03 5.37
MACD 1.24 -0.60
Stochastic Oscillator 93.18 3.26

Price Performance

Historical Comparison
PII
TMDX

About PII Polaris Inc.

Polaris designs and manufactures off-road vehicles, including all-terrain vehicles and side-by-side vehicles for recreational and utility purposes, snowmobiles, and on-road vehicles, along with the related replacement parts, garments, and accessories. The firm entered the marine market after acquiring Boat Holdings in 2018, offering exposure to pontoon and deck boat users. It is slated to divest its Indian motorcycle brand to Carolwood in the first quarter of 2026. Polaris products are retailed through more than 2,500 dealers in North America and 1,500 international dealers as well as more than 25 subsidiaries and 90 distributors in more than 100 countries outside North America.

About TMDX TransMedics Group Inc.

TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System (OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization, and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.

Share on Social Networks: